Search Results for: medical marijuana

Ohio Medical Marijuana Control Program Mandatory Product Recall October 1, 2020

Ohio Medical Marijuana Control Program
Mandatory Product Recall – 10/1/2020
UPDATE
Yesterday, the Ohio Medical Marijuana Control Program (MMCP) issued a mandatory product recall on edible products sold by Mother Grows Best, LLC dba Verano Brands. This recall was initiated by the MMCP because the product did not pass the full battery of required testing and was sold at specific dispensaries (see complete recall notice for product and dispensary information).
The MMCP identified the brand product, Encore Edibles (Dark Chocolate), as exceeding the regulatory thresholds for cadmium. Cadmium is a heavy metal found in soil and water that can be absorbed by and accumulated in plants (including cocoa beans) that are used to make food products. For non-smokers, food is the main source of cadmium intake for the general population. Increased daily exposure to cadmium can pose a health risk to patients.
Ohio Admin. Code 3796:4-2-04(H) states a heavy metal contamination analysis passes for cadmium if “the detected amount of cadmium, if any, is less than 0.09 micrograms per kilogram.” When establishing the thresholds, the MMCP utilized the average body weight assumption for a 10-year-old child. Utilizing this assumption creates a higher standard for MMCP products, with the goal of reducing the maximum daily exposure to heavy metals for patients.
For questions regarding cadmium, please review the following resources:
The MMCP continues to investigate this matter and will provide a comprehensive executive summary once complete. As a reminder, no reports of adverse reactions for this product have been reported to the MMCP at this time.
Anyone who thinks that they may be experiencing serious or life-threatening issues should seek immediate medical attention. Patients are reminded that any adverse reactions should be reported to the MMCP toll-free helpline (1-833-464-6627).

OHIO:  The Ohio Medical Marijuana Control Program (MMCP) is issuing a mandatory product recall on edible products sold by Mother Grows Best. This recall is being initiated by the MMCP because the product did not pass the full battery of required testing and was sold at specific dispensaries (see Product ID information below). Additional details on the specifics of the recall will be provided in the coming days. The MMCP has initiated an investigation into the noncompliance and identified product samples to be tested. These results will be communicated publicly.

AFFECTED PRODUCT:

Product Name: Encore Edibles (Dark Chocolate)

Purchase Dates: 8/17/2020 – 10/1/2020

Processor Name: Mother Grows Best

Product ID:
Sold at Zen Leaf (Canton)
M00000078821: Edb Oral Admin – 10 – 0.4 – 10 – Dark Chocolate Indica
Batch Number: 1A40701000020D1000001083

Sold at Greenleaf Apothecaries (Akron)
M00000078821: Edb Oral Admin – 10 – 0.4 – 10 – Dark Chocolate Indica
Batch Number: 1A40701000020D1000001105

Sold at Greenleaf Apothecaries (Canton)
M00000078821: Edb Oral Admin – 10 – 0.4 – 10 – Dark Chocolate Indica
Batch Number: 1A40701000020D1000001111

Sold at Ohio Cannabis Company (Coshocton)
M00000078821: Edb Oral Admin – 10 – 0.4 – 10 – Dark Chocolate Indica
Batch Number: 1A40701000020D1000001124

Sold at Greenleaf Apothecaries (Cleveland)
M00000078821: Edb Oral Admin – 10 – 0.4 – 10 – Dark Chocolate Indica
Batch Number: 1A40701000020D1000001137

Sold at Greenleaf Apothecaries (Columbus)
M00000078821: Edb Oral Admin – 10 – 0.4 – 10 – Dark Chocolate Indica
Batch Number: 1A40701000020D1000001191

Sold at Pure Ohio Wellness (Dayton)
M00000078821: Edb Oral Admin – 10 – 0.4 – 10 – Dark Chocolate Indica
Batch Number: 1A40701000020D1000001219

Sold at Have a Heart Cincy (Cincinnati)
M00000078821: Edb Oral Admin – 10 – 0.4 – 10 – Dark Chocolate Indica
Batch Number: 1A40701000020D1000001310

No reports of adverse reactions for this product have been reported to the MMCP at this time.

Patients who have purchased the recalled product should stop using it.

All unused product should be returned to the dispensary where purchased. Returned products will not count toward a patient’s 45-day possession limit. For more information on returns, please contact the dispensary where the product was purchased.

Anyone who thinks that they may be experiencing serious or life-threatening issues should seek immediate medical attention. Patients are reminded that any adverse reactions should be reported to the MMCP toll-free helpline (1-833-464-6627).

First Half 2020 Tax Revenues Top $39 Million From Oklahoma Medical Marijuana

OKLAHOMA:  According to statistics released by the Oklahoma Medical Marijuana Authority (OMMA), the Sooner State generated more than $39 Million in tax revenues from its robust medical marijuana program in the first half of 2020.

Oklahoma Medical Marijuana Authority Names New Director

OKLAHOMA:  The deputy director of the Oklahoma Medical Marijuana Authority will serve as interim director of the authority, officials announced Friday.

Kelly Williams replaces Travis Kirkpatrick, who was recently named deputy commissioner of prevention and preparedness at the Oklahoma State Department of Health.

Kirkpatrick, who will oversee the OMMA from his new position, chose Williams for the interim post. Kirkpatrick had been named director of the authority in January after serving as interim director for about three months.

“This is a young agency and we have seen massive growth over the past two years,” Williams said in a statement. “I look forward to the challenges and the rewards of growing the Oklahoma Medical Marijuana Authority into an agency that will make Oklahomans proud.”

Ohio Medical Marijuana Control Program Releases Testing Laboratory Provisional License Application Materials

OHIO:The Ohio Medical Marijuana Control Program (MMCP) is scheduled to accept new testing laboratory license applications beginning the week of August 3, 2020. On its testing laboratories webpage, the MMCP has posted two documents for potential applicants to assist in understanding the key substantive attributes of the application.

Potential applicants may submit questions regarding the application materials using instructions listed on the testing laboratories webpage. All questions must be submitted by July 31, 2020. The MMCP will then provide the frequently asked questions and MMCP answers to potential applicants.

For more information, visit the MMCP’s testing laboratories webpage.

Oklahoma Medical Marijuana Authority Says No To Pot Slushy Machines

OKLAHOMA: The OMMA has received multiple inquiries regarding the processing and dispensing of marijuana-infused slushies on-site at medical marijuana dispensaries.  It is the OMMA’s position that marijuana-infused slushies are unlikely to meet requirements set forth in Oklahoma statutes and rules, including, but not limited to:  

  • All products must be in child-resistant packages. Generally, this means the package must be difficult for a 5-year-old to open; opaque; and, if intended for multiple uses (for example, containing multiple servings), capable of being resealed while remaining child-resistant. [See 63 O.S. 427.2 and OAC 310:681-1-4]
  • The medical marijuana production batch that must be tested is the finished product. In this instance, the finished product is the slushy mixture to be dispensed to patients/caregivers, not the syrup. If water, ice, or any other substance is added to the product, additional testing is required to ensure the product is safe for consumption and final-product labeling is accurate.  [See OAC 310:681-1-4 and OAC 310:681, Subchapters 7 and 8]
  •  Dispensaries are not allowed to alter, package, or label products. In addition, dispensaries must refuse to accept or return any medical marijuana products that have not been properly tested, packaged, and labeled by a licensed processor. [See OAC 310:681-1-4 and OAC 310:681-7-1(b)]

Additionally, slushies are considered food products and must be compliant with the Oklahoma State Department of Health food regulations. For more information, please visit the  OSDH Consumer Health Service Food website.

NJ Department Of Health Issues Permit To Grow Medical Marijuana

NEW JERSEY: The New Jersey Department of Health issued last month a permit to Justice Grown in Ewing to begin growing medical marijuana. The permit was issued after a comprehensive review including several site inspections, background checks of its corporate officers and a review of its security operations and cultivation facility.

“As our program continues to grow, the Department wants to ensure that we also continue to increase access for all patients,” Health Commissioner Judith Persichilli said. “This new permit brings the total number of operational medical marijuana cultivation sites in the state to 12.”

Justice Grown is the last Alternative Treatment Center (ATC) to receive a cultivation permit among the awards made by the Division of Medicinal Marijuana in December 2018. Earlier this year, the Division issued cultivation permits to Verano in Readington, MPX NJ in Pleasantville, TerrAscend in Boonton Township, and Columbia Care NJ in Vineland.

Once Justice Grown receives its permit to dispense, the Division will notify the patients and caregivers by email of the opening date.  Justice Grown’s dispensary will also be located in Ewing.

There are nine ATCs currently dispensing medical marijuana: Greenleaf Compassion Center of Montclair, Compassionate Care Foundation of Egg Harbor, Garden State Dispensary of Woodbridge and Union Township, Breakwater Alternative Treatment Center of Cranbury, Curaleaf NJ, Inc. in Bellmawr, Harmony Dispensary in Secaucus and Rise in Paterson and Compassionate Care Foundation of Atlantic City.

Program participation continues to grow. There are now 75,468 patients, 2,949 caregivers and 1,149 physicians participating in the program.

Patients and caregivers can visit the Division’s website if they choose to change their preferred ATC. The change can also be made by calling the Customer Service Unit of the Division of Medicinal Marijuana at 844-419-9712 and does not require changing ID cards.

Patients can refer to the FAQ section of the Division of Medicinal Marijuana website for additional information. Active physicians enrolled in the program are listed by county and medical specialty.

New Jersey residents interested in registering for Medicinal Marijuana can click here.

Follow the New Jersey Department of Health on Twitter @njdeptofhealth, Facebook /njdeptofhealth, Instagram@njdeptofhealth and Snapchat @njdoh.

For more information, visit our homepage at nj.gov/health.

Ohio Medical Marijuana Control Program Mandatory Product Recall – 3/13/2020

OHIO: The Ohio Medical Marijuana Control Program (MMCP) is issuing a mandatory product recall on plant material cultivated by Pure Ohio Wellness. This recall is being initiated by the MMCP because product that did not receive the full battery of required testing was sold at dispensaries. The product was not tested for heavy metals, water activity, microbials, mycotoxins, or foreign matter. The MMCP has initiated an investigation into the noncompliance and identified product samples to be tested. These results will be communicated publicly.

AFFECTED PRODUCT:

Product Name: Papaya Punch, Hiker’s Blend, and Tahoe Jack

Purchase Dates: May 10, 2019 – Present

Cultivator Name: Pure Ohio Wellness

Product ID:
• M00000022503: Tier 1 Vap-Hybrid-16.4-.04-Papaya Punch
• M00000022504: Tier 1 Vap-Hybrid-16.9-.07-Hikers Blend
• M00000022506: Tier 1 Vap-Hybrid-18.6-.03-Tahoe Jack
• M00000028027: Tier 1 Vap-Hybrid-14.21-0.05
• M00000032648: Tier 1 Vap-Hybrid-14.48-0.03
• M00000036302: Tier 1 Vap-Sativa-15.50-0
• M00000036303: Tier 1 Vap-Sativa-18.50-0
• M00000036307: Tier 1 Vap-Sativa-14.75-0
• M00000039234: Tier 1 Vap-Sativa-18.50-0 (103) 28.3g
• M00000039235: Tier 1 Vap-Sativa-14.75-0 (104) 8.49g
• M00000039236: Tier 1 Vap-Sativa-14.75-0 (104) 28.3g
• M00000039239: Tier 1 Vap-Sativa-14.75-0 (107) 8.49g
• M00000039240: Tier 1 Vap-Sativa-14.75-0 (107) 28.3g
• M00000039241: Tier 1 Vap-Sativa-15.50-0 (108) 8.49g
• M00000039242: Tier 1 Vap-Sativa-15.50-0 (108) 28.3g

No reports of adverse reactions for this product have been reported to the MMCP at this time.

Patients who have purchased the recalled product should stop using it. All unused product should be returned to the dispensary where purchased. Returned products will not count toward a patient’s 90-day possession limit. For more information on returns, please contact the dispensary where the product was purchased.

Anyone who thinks that they may be experiencing serious or life-threatening issues should seek immediate medical attention. Patients are reminded that any adverse reactions should be reported to the MMCP toll-free helpline (1-833-464-6627).

Ohio: OMMCP Issues Update On 11.15.19 Medical Marijuana Recall

OHIO: On November 17, 2019, the Ohio Medical Marijuana Control Program (MMCP) issued an updated mandatory product recall for three products (Pineapple Express, Blue Boi Z7, and Afghani #1). The original recall was issued on November 15, 2019.

The Ohio Department of Commerce mandated that samples of the recalled products be submitted for additional laboratory testing, and subsequently found that all products met the required testing standards for patient use.

The MMCP has completed its review of the One Orijin product recall; completing an executive summary which provides an analysis of the circumstances of the recall. The executive summary can be found here.

The full updated recall notice can be found here.

Ohio Medical Marijuana Advisory Committee March 2020 Meeting Notice

OMMCP

OHIO: The Medical Marijuana Advisory Committee will hold a meeting on March 5, 2020.

ADVISORY COMMITTEE

The Medical Marijuana Advisory Committee is coordinated by the Board of Pharmacy. The Committee may develop and submit to the Department of Commerce, State Board of Pharmacy, and the State Medical Board any recommendations related to the Medical Marijuana Control Program and the implementation and enforcement of the related Ohio Revised Code. Its membership includes the following:

  • Megan E. Marchal, Pharm.D., (Chair), practicing pharmacist and member of the State of Ohio Board of Pharmacy.
  • Stephanie M. Abel, Pharm.D., practicing pharmacist.
  • Tony E. Coder, Jr., representing persons involved in the treatment of drug and alcohol addiction.
  • Michael G. Hirsch, representing agriculture.
  • Sheriff John Lenhart, representing local law enforcement.
  • Jason Kaseman, representing labor.
  • Megan Lawrence, representing caregivers.
  • Dr. Jerry W. Mitchell, Jr., practicing physician.
  • Nancy Walsh Mosca, CNP, practicing nurse.
  • Marcie Seidel, representing persons involved in mental health treatment.
  • Dr. Amol Soin, practicing physician and member of the State Medical Board of Ohio.
  • Michael E. Stanek, representing employers.
  • Gary L. Wenk, engages in academic research.
  • Christopher Stock, representing patients.